DTC Risk Information Placement Can Affect Fair Balance, Academic Tells FDA

Direct-to-consumer ads need to better reflect the effect of risk information placement on patient comprehension of a drug's risk-benefit profile, a Duke University professor told FDA during a public meeting on DTC advertising in Washington, D.C. Sept. 22